Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.577
+0.003 (0.56%)
Jun 29, 2026, 1:12 PM EDT - Market open
Galmed Pharmaceuticals Employees
As of December 31, 2025, Galmed Pharmaceuticals had 6 total employees, including 3 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,718,167
Market Cap
3.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| GRI Bio | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| SciSparc | 3 |
| Onconetix | 2 |
GLMD News
- 7 days ago - Galmed announces restructured acquisition terms for Colospan - TheFly
- 7 days ago - Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd. - PRNewsWire
- 21 days ago - Galmed to acquire Colospan in cash and stock deal - TheFly
- 21 days ago - Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market - PRNewsWire
- 27 days ago - Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis - TheFly
- 27 days ago - Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis - TheFly
- 27 days ago - Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis - PRNewsWire
- 6 weeks ago - Galmed reports results from first-in-man PK study of Aramchol Meglumine - TheFly